Bausch Health Companies (BHC)

Bausch Health Companies Stock Analysis & Ratings



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Bausch Health Companies’s price range in the past 12 months?
Bausch Health Companies lowest stock price was $4.00 and its highest was $29.59 in the past 12 months.
    What is Bausch Health Companies’s market cap?
    Currently, no data Available
    What is Bausch Health Companies’s price target?
    The average price target for Bausch Health Companies is $8.42. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $15.00 ,the lowest forecast is $4.50. The average price target represents 40.10% Increase from the current price of $6.01.
      What do analysts say about Bausch Health Companies?
      Bausch Health Companies’s analyst rating consensus is a ‘Hold. This is based on the ratings of 8 Wall Streets Analysts.
        When is Bausch Health Companies’s upcoming earnings report date?
        Bausch Health Companies’s upcoming earnings report date is Nov 08, 2022 which is in 87 days.
          How were Bausch Health Companies’s earnings last quarter?
          Bausch Health Companies released its earnings results on Aug 09, 2022. The company reported $0.607 earnings per share for the quarter, missing the consensus estimate of $0.907 by -$0.3.
            Is Bausch Health Companies overvalued?
            According to Wall Street analysts Bausch Health Companies’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Bausch Health Companies pay dividends?
              Bausch Health Companies pays a Quarterly dividend of $1 which represents an annual dividend yield of N/A. Bausch Health Companies’s last Quarterly dividend payment was on Dec 22, 2010. Bausch Health Companies’s upcoming ex-dividend date is Nov 10, 2010
                What is Bausch Health Companies’s EPS estimate?
                Bausch Health Companies’s EPS estimate is $0.99.
                  How many shares outstanding does Bausch Health Companies have?
                  Bausch Health Companies has 361,479,700 shares outstanding.
                    What happened to Bausch Health Companies’s price movement after its last earnings report?
                    Bausch Health Companies reported an EPS of $0.607 in its last earnings report, missing expectations of $0.907. Following the earnings report the stock price went down -11.301%.
                      Which hedge fund is a major shareholder of Bausch Health Companies?
                      Among the largest hedge funds holding Bausch Health Companies’s share is Carl Icahn C. It holds Bausch Health Companies’s shares valued at 793M.


                        Bausch Health Companies Stock Analysis

                        Smart Score
                        Price Target
                        ▲(40.10% Upside)
                        The Bausch Health Companies stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Bausch Health Companies

                        Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets.

                        Similar Stocks
                        Price & Change
                        Amphastar Pharmaceuticals
                        Prometheus Biosciences
                        Supernus Pharmaceuticals

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis